stars 1 stars 2 stars 3

Nicoccino has developed an innovative and patented nicotine product that after completion of a clinical study will be classified as a medicine for smoking cessation (Nicotine Replacement Therapy - NRT). Sales to consumers will be managed indirectly through a license model with international partners. Nicoccino`s head quarter is located in Täby outside of Stockholm. The company's share has been listed on Nasdaq First North since June 2014 and can be found under the abbreviation NICO. Remium Nordic AB is Nicoccino Holding's Certified Adviser. This information is information that Nicoccino Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above at 08:00 CET on 18th Oct. 2016. This message has been communicated in Swedish and English. If differences between the versions exist, the Swedish version is pertained.

View Top Employees from Nicoccino Holding AB

Nicoccino Holding AB Questions

The Nicoccino Holding AB annual revenue was $1 million in 2024.

Nicoccino Holding AB is based in Täby, Stockholm.

The NAICS codes for Nicoccino Holding AB are [3122, 31, 31223, 312].

The SIC codes for Nicoccino Holding AB are [213, 21].

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users